Novel BCR-ABL1 tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia

Malik S., Hassan S., EŞKAZAN A. E.

EXPERT REVIEW OF HEMATOLOGY, vol.14, no.11, pp.975-978, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Editorial Material
  • Volume: 14 Issue: 11
  • Publication Date: 2021
  • Doi Number: 10.1080/17474086.2021.1990034
  • Journal Name: EXPERT REVIEW OF HEMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Chemical Abstracts Core, EMBASE, MEDLINE
  • Page Numbers: pp.975-978
  • Keywords: Asciminib, chronic myeloid leukemia, flumatinib, HQP1351, K0706, novel therapies, olverembatinib, PF-114, tyrosine kinase inhibitor, vodobatinib, ASCIMINIB, THERAPY
  • Istanbul University Affiliated: No